NCT02471313 Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization Status COMPLETED Phase PHASE2
NCT02415283 OBT Measurement to Differentiate Between Presence and Absence of HCC Determined by MRI Status UNKNOWN Phase N/A
NCT02232490 Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L Status UNKNOWN Phase PHASE3
NCT02229071 Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT02187081 Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC Status UNKNOWN Phase NA
NCT02182687 Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant Status COMPLETED Phase PHASE2
NCT01871545 Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) Status COMPLETED Phase NA
NCT01387555 A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib Status COMPLETED Phase PHASE2
NCT01356628 A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer Status COMPLETED Phase PHASE2
NCT01265576 Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE2